drugset / Trial / NCT07619443
A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
RandomizedCrossoverOpen-labelBasic science
Summary
The goal of this study is to learn what happens to a single dose of enlicitide over time in a healthy participant's body when the participant is given a single dose of MK-7262 and what happens to a single dose of MK-7262 over time in a healthy participant's body when the participant is given a single dose of enlicitide.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2026-09-05
- Completion
- 2026-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enlicitide | Unknown | — | Oral |
| Subject | MK-7262 | Unknown | — | Oral |
Indications
No indication recorded.